New Perspectives on Antimicrobial Agents: Maribavir
Sign Up to like & getrecommendations! Published in 2022 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.02405-21
Abstract: Maribavir was approved by the U.S. Food and Drug Administration in November 2021 for the treatment of adult and pediatric patients with post-transplant cytomegalovirus (CMV) infection/disease that is refractory to treatment (with or without genotypic… read more here.
Keywords: perspectives antimicrobial; agents maribavir; treatment; cmv ... See more keywords